Skip to main content
Caplight Logo









Xias Bio

Xias Bio

Private
PaisleyHealthcare & Life Scienceshttps://xiasbio.com/

Last Round

Seed

Sep 4, 2024

Total Funding Raised

$5.1M

Company Overview

Xias Bio is a biotechnology company that develops sustainable, animal-free protein alternatives using its proprietary LiteProtein™ engineering platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Sustainable Materials, Fashion & Beauty

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Keywords

recombinant proteinsanimal-free ingredientslab-grown proteinsbiofermentationprotein engineeringsynthetic biologycosmetic ingredientsbiotech manufacturingsustainable beautypeptide designin silico discoverycollagen alternativekeratin alternativeelastin alternativeB2B biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xias Bio Comparables

Compare Xias Bio with similar companies based on industry and business-model similarity.

Xias Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cambrium
88%
Jellatech
85%
Geltor
84%

Xias Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 4, 2024

Key People

Founding team and executive leadership

Faadil Fawzy

Co-Founder & Chief Scientific Officer

Founding Team

Xias Bio Investors

Notable investors and investment history

Xias Bio investors
InvestorRounds
Good StartupSeed
Happiness CapitalSeed
CPT CapitalSeed
IndieBioAccelerator
BoxOne VenturesSeed
SOSVAccelerator, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 7, 2025

    Monthly visitors grew 2240% MoM, reaching 1.1K.

  • Dec 13, 2024

    Grew 50% QoQ, from 6 to 9 employees.

Xias Bio Filings

Explore SEC and related filing metadata, where available.

Xias Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Xias Bio's valuation, stock price, and market status.

Is Xias Bio a public or private company?

Xias Bio is a private company.

What is the current stock price of Xias Bio?

Xias Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Xias Bio worth (valuation)?

Valuation information for Xias Bio is not publicly available.

Can I buy Xias Bio stock?

Xias Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Xias Bio's last funding round?

Xias Bio's most recent funding round was Seed on September 4, 2024.

Who are the main investors in Xias Bio?

Key investors in Xias Bio include Happiness Capital.

Will Xias Bio IPO soon?

No public IPO plans have been announced for Xias Bio.

How can I track Xias Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Xias Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPaisley
Employee Range10
Year Founded2020
Last FundingSep 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?